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In recent years, technological innovations in radiotherapy have been remarkable, thanks to progress in com-
puter technology and therapeutic equipment, and various high precision radiotherapy have been established.
Intensity-modulated radiation therapy (IMRT) can conduct complicated dose calculations by computer con-
trol and inverse planning and allows sufficient target dose applications while keeping the risk organs within the
tolerance dose. Volumetric-modulated arc therapy (VMAT) is an irradiation technique that adds intensity-
modulation to conformal radiotherapy, which shortens the treatment time. Image-guided radiotherapy (IGRT) is
an irradiation technique that reproduces the irradiation position, which is determined by the treatment plan, by
three-dimensional measurements.
Particle therapy is a form of high-precision radiotherapy that uses protons and heavy-particles (carbon-ion),
which are obtained from large accelerators, such as cyclotrons and synchrotrons. Since the particle does not ad-
vance beyond a certain depth, called Bragg peak, it is possible to concentrate the dose onto the lesion. Particle
therapy has the advantage of providing a low radiation dose to risk organs; thus, the risk of adverse events is low.
High-precision radiotherapy is expected to improve treatment outcomes and reduce side effects.
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Fig.　1　A multileaf collimator (MLC)
The MLC contains a large number of highly absorbent 
tungsten leaves that can be positioned individually to 
create field openings with complex shapes. (Photo is 
courtesy of Varian Medical Systems).
Fig.　2　Left, Forward planning of 3D-CRT; Right, In-
verse planning of IMRT
Forward planning: The dose in each irradiation field 
shows a uniform distribution. Inverse planning: The 
dose in each irradiation field shows an intensity 
modulated distribution, which can make concave 
outlines, such as seen in the rectum. (This figure is 



























































Fig.　3　VMAT plan for prostate cancer 
This figure shows a typical prostate VMAT plan, which would be impossible to achieve 
with conventional uniform beams. The machine continuously reshapes and changes the in-
tensity of the radiation beam, as it moves around the body. The height of the bar graph on 











































boost：SIB）の 1例である．腫瘍床領域に 60 Gy/30
fxの照射，浮腫領域に 50 Gy/30fxの照射を同時に
行っている．本症例の計画設定は，計画標的体積
（planning target volume：PTV）の D50である．各リ
スク臓器の線量制約を Table 1に示す．
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Fig.　4　VMAT plan for postoperative brain tumor 
This patient is treated with a simultaneous integrated boost using VMAT. VMAT of 60 
Gy/30 fx to the tumor bed area and 50 Gy/30 fx to the edematous area are simultaneously 
applied. The dark purple color indicates the tumor bed area, while the light purple color 
indicates the edematous area.
Table　1　OAR dose-volume clinical con-
straints of Figure 4
OAR Constraint
Brainstem PRV D2% ＜60 Gy
Optic apparatus D2% ＜52 Gy
Dmax ＜54 Gy
Optic PRV Dmax ＜52 Gy
Eye PRV D2% ＜45 Gy
Lens D2% ＜6 Gy
Spinal Cord Dmax ＜50 Gy
Spinal Cord PRV D2cc ＜46 Gy
Brain V57 Gy ＜1/3 (Grade IV)
V54 Gy ＜1/3 (Grade III)
Cerebrum V54 Gy ＜1/3
Cochlea Dmean ＜42/10 Gy































Fig.　6　Comparison of X-ray and particle beam dose concentrations 
This figure shows a schematic diagram of the dose distribution across the human body. 










































Fig.　7　Comparison of depth-dose plots from X-ray 
and particle beams 
SOBP refers to the sum of several individual Bragg 
peaks of mono-energetic particle beams at staggered 
depths. SOBP 50, spread-out Bragg peak of 50 mm; 
MONO, mono-energetic beam.
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